Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Signs Third Genotyping Deal With Glaxo

NEW YORK, Sept. 1 (GenomeWeb News) - Perlegen Sciences will conduct further genetic analysis studies for GlaxoSmithKline under a new agreement, Perlegen said today.


The companies did not disclose any details of the agreement, other than saying that it "enables multiple genetics related studies to be conducted over a period of time."


Perlegen has conducted two whole-genome association studies for GSK in the past. The first, announced in September 2002, aimed at identifying drug response markers. The second, from October 2004, sought to determine genetic variants associated with a "specific GSK trait of interest."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.